These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3072894)

  • 61. Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients.
    Lithell H; Pollare T; Vessby B
    Blood Press; 1992 Aug; 1(2):92-101. PubMed ID: 1366265
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Atenolol and pindolol interfere with urinary 5-hydroxyindole-3-acetic acid.
    Neftel KA; Gautschi K
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):58-9. PubMed ID: 2420729
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Quantitative data on the additive effect of a beta-receptor blockader and a saluretic in the therapy of hypertension. Interindividual-component comparison in a doble-blind study].
    Werning C; Hammerschmidt D; Kaiser Hj
    Med Welt; 1978 Oct; 29(40):1570-5. PubMed ID: 703579
    [No Abstract]   [Full Text] [Related]  

  • 64. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():163S-6S. PubMed ID: 26635160
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Treatment of essential hypertension with prindolol].
    Kuska J; Sledzinski Z; Kokot F
    Wiad Lek; 1977 Apr; 30(7):505-10. PubMed ID: 855327
    [No Abstract]   [Full Text] [Related]  

  • 66. Randomized comparison of atenolol and placebo in the treatment of anxiety: a double-blind study.
    Saul P; Jones BP; Edwards KG; Tweed JA
    Eur J Clin Pharmacol; 1985; 28 Suppl():109-10. PubMed ID: 4054192
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A long-term study on the effect of pindolol on serum lipoproteins: a preliminary report.
    Carlson LA; Ribacke M; Terent A
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):61S-62S. PubMed ID: 3440110
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.
    Taylor EA; Turner P
    Br J Clin Pharmacol; 1981 Oct; 12(4):543-8. PubMed ID: 7295488
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension.
    Zemel PC; Zemel MB; Urberg M; Douglas FL; Geiser R; Sowers JR
    Am J Clin Nutr; 1990 Apr; 51(4):665-9. PubMed ID: 2181860
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Once-a-day treatment of hypertension with pindolol.
    Frithz G
    Am Heart J; 1982 Aug; 104(2 Pt 2):413-6. PubMed ID: 7102526
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative effects of pindolol and hydrochlorothiazide in black hypertensive patients.
    Moser M; Lunn J
    Angiology; 1981 Aug; 32(8):561-6. PubMed ID: 7258733
    [No Abstract]   [Full Text] [Related]  

  • 72. [Pindolol in the treatment of arterial hypertension].
    Rev Prat; 1979 Jan; 29(3):402. PubMed ID: 419363
    [No Abstract]   [Full Text] [Related]  

  • 73. Atenolol versus pindolol: side-effects in hypertension.
    Foerster EC; Greminger P; Siegenthaler W; Vetter H; Vetter W
    Eur J Clin Pharmacol; 1985; 28 Suppl():89-91. PubMed ID: 4054195
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vertebral hyperostosis and diabetes mellitus: a case-control study.
    Daragon A; Mejjad O; Czernichow P; Louvel JP; Vittecoq O; Durr A; Le Loët X
    Ann Rheum Dis; 1995 May; 54(5):375-8. PubMed ID: 7794043
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
    Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ; Jaguste V; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension].
    Herpin D; Guillard O; Piriou A; Amiel A; Boutaud P; Ciber MA; Demange J
    Ann Med Interne (Paris); 1988; 139(7):484-7. PubMed ID: 3072894
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.